DeepAI
Log In Sign Up

Sample size for a non-inferiority clinical trial with time-to-event data in the presence of competing risks

02/28/2018
by   Dong Han, et al.
0

The analysis and planning methods for competing risks model have been described in the literatures in recent decades, and non-inferiority clinical trials are helpful in current pharmaceutical practice. Analytical methods for non-inferiority clinical trials in the presence of competing risks were investigated by Parpia et al., who indicated that the proportional sub-distribution hazard model is appropriate in the context of biological studies. However, the analytical methods of competing risks model differ from those appropriate for analyzing non-inferiority clinical trials with a single outcome; thus, a corresponding method for planning such trials is necessary. A sample size formula for non-inferiority clinical trials in the presence of competing risks based on the proportional sub-distribution hazard model is presented in this paper. The primary endpoint relies on the sub-distribution hazard ratio. A total of 120 simulations and an example based on a randomized controlled trial verified the empirical performance of the presented formula. The results demonstrate that the empirical power of sample size formulas based on the Weibull distribution for non-inferiority clinical trials with competing risks can reach the targeted power.

READ FULL TEXT

page 1

page 2

page 3

page 4

06/25/2021

Implementation of an alternative method for assessing competing risks: restricted mean time lost

In clinical and epidemiological studies, hazard ratios are often applied...
09/21/2020

Sample Size Calculation for Cluster Randomized Trials with Zero-inflated Count Outcomes

Cluster randomized trails (CRT) have been widely employed in medical and...
03/06/2019

Blinded continuous information monitoring of recurrent event endpoints with time trends in clinical trials

Blinded sample size re-estimation and information monitoring based on bl...
10/05/2020

The use of restricted mean time lost under competing risks data

Background: Under competing risks, the commonly used sub-distribution ha...
06/20/2021

Combined tests based on restricted mean time lost for competing risks data

Competing risks data are common in medical studies, and the sub-distribu...